Cytomedix
-
Two stem cell therapies from Cytomedix to start trials; stroke study expands
When regenerative medicine firm Cytomedix (OTC:CMXI) acquired biotechnology company Aldagen, the stem cell-based stroke treatment […]
-
CMXI’s Aldagen acquisition is no exit; stem cell payoff is still down the road
Cytomedix‘s (OTC:CMXI) Aldagen acquisition signaled the company’s intention to establish a strong presence in regenerative […]
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.
-
Stem cell therapeutics firm Aldagen acquired by Cytomedix in stock deal
Regenerative medicine company Cytomedix (OTC:CMXI) has acquired North Carolina stem cell technology company Aldagen in […]